Cytomegalovirus prophylaxis after heart transplantation using specific hyperimmunoglobulin
Schäfers, H.J.; Haverich, A.; Wahlers, T.; Milbradt, H.; Flik, J.; Fieguth, H.G.; Borst, H.G.
Transplantation Proceedings 19(5): 4061-4062
1987
ISSN/ISBN: 0041-1345 PMID: 2823430 Document Number: 288456
Document emailed within 1 workday
Related Documents
Laske, A.; Gallino, A.; Carrel, T.; Niederhäuser, U.; von Segesser, L.K.; Turina, M.I. 1993: Cytomegalovirus infection and prophylaxis in heart transplantation Transplantation Proceedings 25(1 Part 2): 1427-1428Fassbinder, W.; Bechstein, P.B.; Scheuermann, E.H.; Schoeppe, W. 1985: Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin Scandinavian Journal of Urology and Nephrology. Supplementum 92: 23-28
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Tinelli, M.; Percivalle, E.; Zambelli, A.; Grossi, P.; Maccabruni, A. 1990: Cytomegalovirus prophylaxis by intravenous immunoglobulins in five heart transplanted patients Bollettino dell'Istituto Sieroterapico Milanese 69(2): 459-467
Steinmuller, D.R.; Graneto, D.; Swift, C.; Novick, A.C.; Streem, S.B.; Cunningham, R.J.; Hodge, E.; Bretan, P. 1989: Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation Transplantation Proceedings 21(1 Pt 2): 2069-2071
Laske, A.; Carrel, T.; Niederhäuser, U.; Bauer, E.; Pasic, M.; von Segesser, L.K.; Gallino, A.; Turina, M. 1992: Prevention of cytomegalovirus infection following heart transplantation Helvetica Chirurgica Acta 58(4): 527-532
Kawalec, P.ł; Holko, P.ła.; Szkultecka-Debek, M.; Paszulewicz, A.; Boratyńska, M.; Głyda, M.; Ignacak, E.; Maks, J.; Russel-Szymczyk, M.; Kaweczyńska-Lasoń, A. 2013: The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 332-338
Zegelman, M.; Satter, P.; Giesel, M. 1987: Cytomegalovirus infections following heart surgery. a prospective study of specific antibodies Helvetica Chirurgica Acta 53(4): 501-504
Koskinen, P.; Nieminen, M.; Mattila, S.; Lautenschlager, I. 1993: Quantitative immunodetection of cytomegalovirus antigenemia in the clinical diagnosis of CMV infection after heart transplantation Transplantation Proceedings 25(1 Part 2): 1426
Bramwell, N.H.; Davies, R.A.; Koshal, A.; Tse, G.N.; Keon, W.J.; Walley, V.M. 1987: Fatal gastrointestinal hemorrhage caused by cytomegalovirus duodenitis and ulceration after heart transplantation Journal of Heart Transplantation 6(5): 303-306
Locke, T.J.; Odom, N.J.; Tapson, J.S.; Freeman, R.; McGregor, C.G. 1987: Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation Journal of Heart Transplantation 6(2): 120-122
Adler, S.P.; Nigro, G. 2008: The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease Herpes: the Journal of the Ihmf 15(2): 24-27
Kormos, R.L.; Herlan, D.B.; Armitage, J.M.; Stein, K.; Kaufman, C.; Zeevi, A.; Duquesnoy, R.; Hardesty, R.L.; Griffith, B.P. 1990: Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation Journal of Heart Transplantation 9(1): 1-9; Discussion: 9-10
Frist, W.H.; Merrill, W.H.; Eastburn, T.E.; Stewart, J.R.; Hammon, J.W.; Fortune, D.S.; Guy, T.S.; Bender, H.W. 1991: Nashville antithymocyte serum: a safe and efficacious agent for prophylaxis after heart transplantation Transplantation Proceedings 23(1 Part 2): 1160-1161
Lautenschlager, I.; Ahonen, J.; Eklund, B.; Höckerstedt, K.; Isoniemi, H.; Salmela, K.; Häyry, P. 1990: Detection of cytomegalovirus-specific early antigens from blood leukocytes and bronchoalveolar lavage cells in the diagnosis of active cytomegalovirus infection in transplant patients Transplantation Proceedings 22(1): 233
Costanzo-Nordin, M.R.; O'Sullivan, E.J.; Johnson, M.R.; Winters, G.L.; Pifarre, R.; Radvany, R.; Zucker, M.J.; Scanlon, P.J.; Robinson, J.A. 1990: Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation Journal of Heart Transplantation 9(3 Part 2): 306-315
Mihăilescu, R.; Arama, V.; Paraschiv, S.; Streinu-Cercel, A.; Oţelea, D.; Munteanu, D.; Iosipenco, M.; Chiotan, C.; Benea, O.E.; Mărdărescu, M.; Rădulescu, M.; Hristea, A.; Ungurianu, R.; Aramă, S.S.; Cercel, A.S.; Călin, R.; Băicuş, C. 2008: Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy Romanian Journal of Internal Medicine 46(4): 305-311
Aldershvile, J.; Boesgaard, S.; Kirchoff, G.; Arendrup, H.; Høyer, S. 1993: Danish experience with physical and occupational rehabilitation after heart transplantation. the heart transplantation group at Rigshospitalet Ugeskrift for Laeger 155(2): 98-100
Nesralla, I.A.; da Silva, J.P.; de Mendonça, J.T.; Fortunato, J.A. 1999: I Guidelines of the Brazilian Cardiology Society for Heart Transplantation: VII. Technical aspects of heart transplantation Arquivos Brasileiros de Cardiologia 73 Suppl. 5: 45-51
Harland, R.C.; Vernon, W.B.; Bunzendahl, H.; Thompson, J.K.; Lawrence, C.; Bollinger, R.R. 1994: Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients Transplantation Proceedings 26(2): 432-433